Nuclear β-catenin expression in basal cell adenomas of salivary gland

Journal of Oral Pathology and Medicine

Volumn 40, Issue 6, 2011, Pages 460-466

  Kawahara, Akihiko ^a   Harada, Hiroshi ^b   Abe, Hideyuki ^a   Yamaguchi, Tomohiko ^a   Taira, Tomoki ^a   Nakashima, Kazutaka ^a   Mihashi, Hiroyuki ^c   Akiba, Jun ^c   Kage, Masayoshi ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b SAKAI MUNICIPAL HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basal cell adenoma; Basaloid myoepithelial cells; CTNNB1; Nuclear catenin

Indexed keywords

BETA CATENIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CHILD; CONTROLLED STUDY; CTNNB1 GENE; DNA SEQUENCE; EXON; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND TUMOR; PATIENT SELECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND TUMOR; SCHOOL CHILD; TUMOR GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOMA; ADULT; AGED; BETA CATENIN; CELL NUCLEUS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROTID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959964211     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01010.x     Document Type: Article

References (35)

1. Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005; 261-2.
2. Nagao K, Matsuzaki O, Saiga H, et al. Histopathologic studies of basal cell adenoma of the parotid gland. Cancer 1982; 50: 736-45.
3. Ellis GL, Auclair PL. Atlas of tumor pathology series 4: tumour of the salivary glands. Washington, DC: Armed Forces Institute of Pathology, 2008.
4. Kawahara A, Harada H, Akiba J, Yokoyama T, Kage M. Fine needle aspiration cytology of basal cell adenoma of the parotid gland: characteristic cytological features and diagnostic pitfalls. Diagn Cytopathol 2007; 35: 85-90.
5. Lazǎr D, Tǎban S, Ardeleanu C, et al. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival. Rom J Morphol Embryol 2008; 49: 459-67.
6. Ogawa M, Watanabe M, Eto K, et al. Poorly differentiated adenocarcinoma of the colon and rectum: clinical characteristics. Hepatogastroenterology 2008; 55: 907-11.
7. Shibuya Y, Ri S, Umeda M, et al. Ultrastructural localization of E-cadherin and alpha-/beta-catenin in adenoid cystic carcinoma. Histopathology 1999; 35: 423-31.
8. Bläker H, Scholten M, Sutter C, Otto HF, Penzel R. Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation. Am J Clin Pathol 2003; 120: 418-23.
9. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 2004; 10: 1401-8.
10. Tadjine M, Lampron A, Ouadi L, Bourdeau I. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol (Oxf) 2008; 68: 264-70.
11. Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C. Hepatocellular adenoma: what is new in 2008. Hepatol Int 2008; 2: 316-21.
12. Buslei R, Hölsken A, Hofmann B, et al. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol 2007; 113: 585-90.
13. Chetty R, Serra S, Salahshor S, et al. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis. Hum Pathol 2006; 37: 212-7.
14. Kim MJ, Jang SJ, Yu E. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Hum Pathol 2008; 39: 251-8.
15. Furuse C, Cury PR, Altemani A, et al. Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol 2006; 14: 212-7.
16. do Prado RF, Consolaro A, Taveira LA. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. Med Oral Patol Oral Cir Bucal 2006; 11: 247-51.
17. Genelhu MC, Gobbi H, Arantes DC, Cardoso SV, Cassali GD. Immunolocalization of beta-catenin in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Appl Immunohistochem Mol Morphol 2007; 15: 273-8.
18. Daa T, Kaku N, Kashima K, Nakayama I, Yokoyama S. Expression of beta-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland. J Exp Clin Cancer Res 2005; 24: 83-7.
19. Zhou CX, Gao Y. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep 2006; 16: 505-11.
20. Shiratsuchi H, Nakashima T, Hirakawa N, et al. Beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression. Head Neck 2007; 29: 577-84.
21. Fonseca I, Fonseca R, Martins C, Soares J. Alteration of beta-catenin localization in salivary pleomorphic adenomas is not related to t(3;8)(p21;q12) and is mainly present in non-epithelial cell types. Histopathology 2008; 52: 244-7.
22. Shieh YS, Chang LC, Chiu KC, Wu CW, Lee HS. Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage, and patient outcome. J Oral Pathol Med 2003; 32: 297-304.
23. do Prado RF, Cardoso CL, Consolaro A, de Assis Taveira LA. Nuclear beta-catenin in basal cell adenomas. Int J Surg Pathol 2007; 15: 219-20.
24. Daa T, Kashima K, Kaku N, Suzuki M, Yokoyama S. Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma. Mod Pathol 2004; 17: 1475-82.
25. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988; 55: 619-25.
26. Röijer E, Kas K, Behrendt M, Van de Ven W, Stenman G. Fluorescence in situ hybridization mapping of breakpoints in pleomorphic adenomas with 8q12-13 abnormalities identifies a subgroup of tumors without PLAG1 involvement. Genes Chromosom Cancer 1999; 24: 78-82.
27. Nishida N, Fukuda Y, Komeda T, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994; 54: 3107-10.
28. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
29. Kim YD, Park CH, Kim HS, et al. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma. J Gastroenterol Hepatol 2008; 23: 110-8.
30. Wani Y, Saegusa M, Notohara K. Aberrant nuclear beta-catenin expression in the spindle or corded cells in so-called corded and hyalinized endometrioid carcinomas. Another critical role of the unique morphological feature. Histol Histopathol 2009; 24: 149-55.
31. Du Q, Zhang X, Cardinal J, et al. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res 2009; 69: 3764-71.
32. Song S, Mazurek N, Liu C, et al. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res 2009; 69: 1343-9.
33. Kandasamy J, Smith A, Diaz S, Rose B, O'Brien C. Heterogeneity of PLAG1 gene rearrangements in pleomorphic adenoma. Cancer Genet Cytogenet 2007; 177: 1-5.
34. Queimado L, Lopes CS, Reis AM. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors. Genes Chromosom Cancer 2007; 46: 215-25.
35. Queimado L, Obeso D, Hatfield MD, et al. Dysregulation of Wnt pathway components in human salivary gland tumors. Arch Otolaryngol Head Neck Surg 2008; 134: 94-101.